Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2024

Shareholders' Equity

Schedule of stockholders equity

	Three-Month Period Ended March 31, 2024 ($000’s omitted)
							Accumulated
			Capital in				Other						Total
	Common		Excess of		Retained		Comprehensive				Treasury		Shareholders’
	Stock		Par Value		Earnings		Loss		ESOT		Stock		Equity
December 31, 2023	$	525	$	14,617	$	12,954	$	(2,389)	$	(56)	$	(1,157)	$	24,494
Retirement benefits adjustment		—		—		—		19		—		—		19
Stock based compensation		—		44		—		—		—		19		63
Net Loss		—		—		(383)		—		—		—		(383)
March 31, 2024	$	525	$	14,661	$	12,571	$	(2,370)	$	(56)	$	(1,138)	$	24,193

	Three-Month Period Ended December 31, 2023 ($000’s omitted)
							Accumulated
			Capital in				Other						Total
	Common		Excess of		Retained		Comprehensive				Treasury		Shareholders’
	Stock		Par Value		Earnings		Loss		ESOT		Stock		Equity
December 31, 2022	$	523	$	14,556	$	23,741	$	(2,337)	$	(157)	$	(1,214)	$	35,112
Retirement benefits adjustment		—		—		—		13		—		—		13
Stock based compensation		—		17		—		—		—		24		41
Net Loss		—		—		(1,547)		—		—		—		(1,547)
March 31, 2023	$	523	$	14,573	$	22,194	$	(2,324)	$	(157)	$	(1,190)	$	33,619

Schedule of earnings per share

	Three-Month Periods Ended
	March 31,
	2024		2023
	($000’s omitted except per share data)
Loss from continuing operations	$	(366)	$	(980)
Loss from discontinued operation		(17)		(567)
Net loss	$	(383)	$	(1,547)
Weighted average common shares outstanding (basic)		2,490		2,460
Unvested restricted stock		29		24
Weighted average common shares outstanding (diluted)		2,519		2,484
Basic and diluted loss per share
Continuing operations	$	(0.15)	$	(0.40)
Discontinued operation		(0.01)		(0.23)
Basic and diluted earnings per share	$	(0.16)	$	(0.63)

Summary of restricted stock activity

		Weighted
		Average Grant
	Shares	Date Fair Value
Restricted Share Activity:
Unvested at December 31, 2023	22,448	$	11.45
Granted in 2024	8,966	$	12.90
Vested in 2024	(2,600)	$	12.01
Unvested at March 31, 2024	28,814	$	11.85